Clinical Trials Browser

Withdrawn × Olanzapine × Clear all

NCT05403580 2024-05-06

Olanzapine for the Treatment of Chronic Nausea and/or Vomiting in Patients With Advanced Cancer

Phase 3 Withdrawn

Other hematologic neoplasm

Hematologic Neoplasms

NCT03960151 2019-05-22

Rolapitant Plus Olanzapine in Multiday Cisplatin Chemotherapy

Phase 2 Withdrawn

Neoplasms, Germ Cell and Embryonal

NCT00737191 2012-03-09

Opioids With or Without Olanzapine in Treating Patients With Moderate to Severe Cancer Pain

Phase NA Withdrawn

Other hematologic neoplasm

Pain, Hematologic Neoplasms